药易购
(300937)
| 流通市值：15.94亿 | | | 总市值：23.51亿 |
| 流通股本：6486.42万 | | | 总股本：9566.67万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,180,537,149.98 | 1,113,920,597 | 4,454,001,549.38 | 3,242,124,750.68 |
| 营业总成本 | 2,180,778,585.96 | 1,099,524,353.69 | 4,421,142,447.4 | 3,215,835,561.02 |
| 其他经营收益 | | | | |
| 营业利润 | -11,791,934.99 | 2,843,769.84 | 8,920,686.13 | 4,023,212.04 |
| 利润总额 | -12,808,313.33 | 2,822,448.43 | 7,177,327.12 | 3,584,893.96 |
| 净利润 | -13,844,461.76 | 1,183,612.15 | -16,455,729.79 | -8,205,143.51 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -13,844,461.76 | 1,183,612.15 | -16,455,729.79 | -8,205,143.51 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,605,472,488.13 | 1,562,490,338.2 | 1,402,571,830.69 | 1,543,767,008.79 |
| 非流动资产: | | | | |
| 非流动资产合计 | 326,760,504.51 | 328,457,198.29 | 319,974,077.39 | 321,990,751.49 |
| 资产总计 | 1,932,232,992.64 | 1,890,947,536.49 | 1,722,545,908.08 | 1,865,757,760.28 |
| 流动负债: | | | | |
| 流动负债合计 | 1,118,232,980.03 | 1,071,194,932.39 | 904,113,020.73 | 1,021,776,164.11 |
| 非流动负债: | | | | |
| 非流动负债合计 | 27,580,712.17 | 18,392,409.84 | 19,836,344.62 | 23,344,698.53 |
| 负债合计 | 1,145,813,692.2 | 1,089,587,342.23 | 923,949,365.35 | 1,045,120,862.64 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 811,281,431.05 | 818,088,098.56 | 820,808,268.16 | 831,608,346.85 |
| 股东权益合计 | 786,419,300.44 | 801,360,194.26 | 798,596,542.73 | 820,636,897.64 |
| 负债和股东权益合计 | 1,932,232,992.64 | 1,890,947,536.49 | 1,722,545,908.08 | 1,865,757,760.28 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,768,478,642.94 | 1,017,477,923.13 | 3,930,498,522.29 | 2,541,090,726.16 |
| 经营活动现金流出小计 | 1,761,331,519.12 | 946,086,651.92 | 3,943,723,815 | 2,655,246,031.83 |
| 经营活动产生的现金流量净额 | 7,147,123.82 | 71,391,271.21 | -13,225,292.71 | -114,155,305.67 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 5,904,914.45 | 8,174.8 | 70,914,976.26 | 15,825,651.87 |
| 投资活动现金流出小计 | 151,977,202.75 | 143,027,615.16 | 49,971,466.78 | 32,856,114.08 |
| 投资活动产生的现金流量净额 | -146,072,288.3 | -143,019,440.36 | 20,943,509.48 | -17,030,462.21 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 126,195,921.53 | 40,166,000 | 391,061,119.35 | 231,242,611.39 |
| 筹资活动现金流出小计 | 30,047,259.09 | 4,033,314.91 | 471,323,578.44 | 237,314,487.12 |
| 筹资活动产生的现金流量净额 | 96,148,662.44 | 36,132,685.09 | -80,262,459.09 | -6,071,875.73 |
| 汇率变动对现金及现金等价物的影响 | 11,998.59 | -4,381.54 | -3,697.23 | -1,356.97 |
| 现金及现金等价物净增加额 | -42,764,503.45 | -35,499,865.6 | -72,547,939.55 | -137,259,000.58 |
| 期末现金及现金等价物余额 | 119,593,813.75 | 126,858,451.6 | 162,358,317.2 | 97,435,307.21 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -42,764,503.45 | - | -72,547,939.55 | - |